Towards Healthcare
U.S. Cell Therapy Market Size | 21.46% - CAGR Growth Report

U.S. Cell Therapy Market Size to Hit $ 38.08 Bn by 2033

The report covers U.S. Cell Therapy Market Growth Analysis of therapy types including both allogeneic and autologous approaches. Allogeneic therapies encompass stem cell therapies such as hematopoietic and mesenchymal stem cell treatments, alongside non-stem cell therapies like keratinocyte and fibroblast-based therapies among others. Autologous therapies feature with T-cell therapies including CAR T cell therapy and T cell receptor (TCR)-based treatments. Therapeutic areas focuses oncology, dermatology and other specialized fields. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Dynamics

  • Trends and Drivers
  • Challenges and Barriers

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

U.S. Cell Therapy Market Assessment

  • Overview
  • U.S. Cell Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapy Type (2021 – 2033)
    • Allogeneic Therapies
      • Stem Cell Therapies
        • Hematopoietic Stem Cell Therapies
        • Mesenchymal Stem Cell Therapies
      • Non-Stem Cell Therapies
        • Keratinocytes & Fibroblast-based Therapies
        • Others
    • Autologous Therapies
      • T-Cell Therapies
        • CAR T Cell Therapy
        • T Cell Receptor (TCR)-based
      • Others
  • U.S. Cell Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Area (2021 – 2033)
    • Oncology
    • Dermatology
    • Others

Cross Segments Analysis

By Therapy Type

  • Allogeneic Therapies
    • Overview
    • Oncology
    • Dermatology
    • Others
  • Stem Cell Therapies
    • Hematopoietic Stem Cell Therapies
      • Overview
      • Oncology
      • Dermatology
      • Others
    • Mesenchymal Stem Cell Therapies
      • Overview
      • Oncology
      • Dermatology
      • Others
  • Non-Stem Cell Therapies
    • Keratinocytes & Fibroblast-based Therapies
      • Overview
      • Oncology
      • Dermatology
      • Others
    • Others
      • Overview
      • Therapeutic Applications
  • Autologous Therapies
    • T-Cell Therapies
      • CAR T Cell Therapy
        • Overview
        • Oncology
        • Dermatology
        • Others
      • T Cell Receptor (TCR)-based
        • Overview
        • Oncology
        • Dermatology
        • Others
    • Others
      • Overview
      • Therapeutic Applications

By Therapeutic Area

  • Oncology
    • Allogeneic Therapies
      • Overview
      • Specific Applications
    • Stem Cell Therapies
      • Hematopoietic Stem Cell Therapies
        • Overview
        • Specific Applications
      • Mesenchymal Stem Cell Therapies
        • Overview
        • Specific Applications
    • Non-Stem Cell Therapies
      • Keratinocytes & Fibroblast-based Therapies
        • Overview
        • Specific Applications
      • Others
        • Overview
        • Specific Applications
    • Autologous Therapies
      • T-Cell Therapies
        • CAR T Cell Therapy
          • Overview
          • Specific Applications
        • T Cell Receptor (TCR)-based
          • Overview
          • Specific Applications
      • Others
        • Overview
        • Specific Applications
  • Dermatology
    • Allogeneic Therapies
      • Overview
      • Specific Applications
    • Stem Cell Therapies
      • Hematopoietic Stem Cell Therapies
        • Overview
        • Specific Applications
      • Mesenchymal Stem Cell Therapies
        • Overview
        • Specific Applications
    • Non-Stem Cell Therapies
      • Keratinocytes & Fibroblast-based Therapies
        • Overview
        • Specific Applications
      • Others
        • Overview
        • Specific Applications
    • Autologous Therapies
      • T-Cell Therapies
        • CAR T Cell Therapy
          • Overview
          • Specific Applications
        • T Cell Receptor (TCR)-based
          • Overview
          • Specific Applications
      • Others
        • Overview
        • Specific Applications
  • Others
    • Allogeneic Therapies
      • Overview
      • Specific Applications
    • Stem Cell Therapies
      • Hematopoietic Stem Cell Therapies
        • Overview
        • Specific Applications
      • Mesenchymal Stem Cell Therapies
        • Overview
        • Specific Applications
    • Non-Stem Cell Therapies
      • Keratinocytes & Fibroblast-based Therapies
        • Overview
        • Specific Applications
      • Others
        • Overview
        • Specific Applications
    • Autologous Therapies
      • T-Cell Therapies
        • CAR T Cell Therapy
          • Overview
          • Specific Applications
        • T Cell Receptor (TCR)-based
          • Overview
          • Specific Applications
      • Others
        • Overview
        • Specific Applications

Integration of AI in U.S. Cell Therapy Market

  • Introduction to AI in Cell Therapy
    • Overview of AI Technologies
    • Role of AI in Cell Therapy
  • AI Applications in Cell Therapy
    • Data Analysis and Interpretation
      • Predictive Analytics
      • Pattern Recognition
    • Treatment Personalization
      • Patient-Specific Treatment Plans
      • Adaptive Therapy Models
    • Drug Discovery and Development
      • Identifying Potential Therapeutic Targets
      • Accelerating Preclinical Studies
    • Clinical Trials Optimization
      • Patient Recruitment and Retention
      • Trial Design and Monitoring
  • AI in Cell Therapy Manufacturing
    • Process Automation
      • Automation of Production Processes
      • Quality Control and Assurance
    • Supply Chain Management
      • Inventory Management
      • Logistics Optimization
  • AI-Driven Diagnostics
    • Disease Detection and Prognosis
      • Early Detection of Target Diseases
      • Prognostic Models for Disease Progression
    • Biomarker Discovery
      • Identifying and Validating Biomarkers
  • AI and Regulatory Compliance
    • Regulatory Guidelines for AI Integration
      • FDA Guidelines and Approvals
      • Ethical Considerations
    • Data Privacy and Security
      • Ensuring Patient Data Protection
      • Compliance with HIPAA and Other Regulations
  • Case Studies
    • Successful AI Implementations
      • Examples from Leading Companies
      • Impact on Treatment Outcomes
    • Lessons Learned and Challenges
      • Challenges Faced During AI Integration
      • Strategies for Overcoming Barriers
  • Future Trends and Innovations
    • Emerging AI Technologies
      • Advances in Machine Learning and Deep Learning
      • Future Applications in Cell Therapy
    • Impact on Market Dynamics
      • Market Opportunities and Threats
      • Potential for Disruption

Production and Consumption Analysis

  • Introduction
    • Overview of Production and Consumption Data
  • Production Data
    • Production Overview
    • Production by Therapy Type
      • Allogeneic Therapies
      • Stem Cell Therapies
        • Hematopoietic Stem Cell Therapies
        • Mesenchymal Stem Cell Therapies
      • Non-Stem Cell Therapies
        • Keratinocytes & Fibroblast-based Therapies
        • Others
      • Autologous Therapies
        • T-Cell Therapies
          • CAR T Cell Therapy
          • T Cell Receptor (TCR)-based
        • Others
    • Production by Therapeutic Area
      • Oncology
      • Dermatology
      • Others
  • Consumption Data
    • Consumption Overview
    • Consumption by Therapy Type
      • Allogeneic Therapies
      • Stem Cell Therapies
        • Hematopoietic Stem Cell Therapies
        • Mesenchymal Stem Cell Therapies
      • Non-Stem Cell Therapies
        • Keratinocytes & Fibroblast-based Therapies
        • Others
      • Autologous Therapies
        • T-Cell Therapies
          • CAR T Cell Therapy
          • T Cell Receptor (TCR)-based
        • Others
    • Consumption by Therapeutic Area
      • Oncology
      • Dermatology
      • Others
  • Analysis and Insights
    • Trends in Production and Consumption
    • Key Drivers and Challenges

Opportunity Assessment

  • New Product Development
    • Emerging Trends in Cell Therapy
    • Innovation in Therapy Types
    • Case Studies of Recent Product Launches
  • Plan Finances/ROI Analysis
    • Financial Projections and Budgets
    • Return on Investment (ROI) Metrics
    • Cost-Benefit Analysis of Cell Therapy Investments
  • Supply Chain Intelligence/Streamline Operations
    • Overview of Supply Chain for Cell Therapies
    • Strategies for Optimizing Supply Chain Efficiency
    • Risk Management in Supply Chain
  • Cross-Border Intelligence
    • Market Opportunities in International Markets
    • Regulatory Considerations for Cross-Border Operations
    • Partnership and Collaboration Opportunities Abroad
  • Business Model Innovation
    • Emerging Business Models in Cell Therapy
    • Case Studies of Successful Business Model Adaptations
    • Strategic Recommendations for Business Model Enhancement
  • Blue Ocean vs. Red Ocean Strategies
    • Analysis of Blue Ocean Strategies in Cell Therapy
    • Competitive Landscape and Red Ocean Strategies
    • Strategic Recommendations for Differentiation and Market Expansion

Company Profiles

  • Aurion Biotech
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Vertex Pharmaceuticals Incorporated
  • Cellular Biomedicine Group, Inc
  • Nkarta, Inc
  • Atara Biotherapeutics, Inc
  • Johnson & Johnson
  • CARGO Therapeutics, Inc.
  • Bristol-Myers Squibb Company
  • Selecta Bioscience
  • Gilead Sciences, Inc.

Regulatory and Policy Framework

  • Overview of Regulatory Environment
    • U.S. Regulatory Agencies
    • Regulatory Pathways for Cell Therapies
    • Compliance and Standards
  • Policy Impacts
    • Healthcare Policy and Reimbursement
    • Legislation Affecting Cell Therapy
    • Ethical and Legal Considerations
  • Future Outlook and Opportunities
    • Anticipated Regulatory Changes
    • Opportunities for Policy Advocacy
    • Impact on Market Dynamics

Emerging Trends

  • Technological Innovations
    • Advancements in Cell Therapy Technologies
    • Integration with Digital Health
  • Market Developments
    • New Product Introductions
    • Investment and Funding Trends
  • Consumer and Patient Trends
    • Changing Patient Preferences
      • Trends in Patient Expectations and Demand
    • Adoption Rates and Market Penetration

Appendices

  • Definitions and Terminology
  • References
  • Insight Code: 5159
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

Gene therapy is the transfer of genetic material, often in the form of a vector or carrier, and the absorption of the gene into the relevant body cells. Cells with the appropriate function are transferred into the patient during cell therapy.

With CAR T treatment, cancer cells are targeted by genetically altered T cells from the patients own immune system or those of a donor.

Centers for Disease Control and Prevention, American Heart Association, National Institute of Environmental Health Sciences, National Cancer Institute, and American Society of Gene & Cell Therapy.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515